Anakinra Helpful in Moderate to Severe COVID-19 With Hyperinflammatory Response
NEW YORK (Reuters Health) – Anakinra may improve prognosis in hospitalized COVID-19 patients w...
In COVID Hangover, as More Around World Get Vaccinated, Fewer Give Blood
SEOUL (Reuters) – From Seoul to Paris, and M...
One-third of SARS-CoV-2 Infections May Be Asymptomatic
(Reuters) – Roughly one-third of people infe...
Parts of Europe Raise Defences and Push Vaccines as Delta Advances
ROME (Reuters) – Looking to counter the incr...
Mass-Testing Reduced Liverpool COVID-19 Cases by a Fifth, Study Finds
LONDON (Reuters) – A mass rapid-testing sche...
Indonesia Readies More Medical Options for Worst-Case Coronavirus Scenario
JAKARTA (Reuters) – Indonesia has prepared b...
Most States COVID-19 Vaccination Plans Created Without Advice on Health Equity
(Reuters Health) – Most states created their...
ECDC Warns Delta Variant to Become 90% Prevalent in EU by End-August
PARIS (Reuters) – The European Centre for Di...
Brazil Passes Half a Million COVID-19 Deaths, Experts Warn of Worse Ahead
SAO PAULO (Reuters) – Brazil’s death t...
Moscow Facing New Aggressive Coronavirus Variant, Mayor Says
MOSCOW (Reuters) – Moscow is facing a new co...